切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - RET - ETB Receptors - 5-HT7 Receptors - Aldehyde Dehydrogenases

10 件产品

每页
清除全部
  1. Alda 1
    B5508 Alda 1
    Target: Aldehyde Dehydrogenases
    Summary: ALDH2激活剂
      ≥15.15 mg/mL
      insoluble in H2O
  2. IRL-2500
    B6872 IRL-2500
    Target: ETA Receptors|ETB Receptors
    Summary: 内皮素受体拮抗剂
  3. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  4. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  5. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  6. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  7. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  8. AST 487
    A3194 AST 487
     1 Citation
    Target: RET
    Summary: RET激酶抑制剂
      ≥26.5 mg/mL
      insoluble in H2O
  9. ENMD-2076
    A4130 ENMD-2076
    Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-Fms
    Summary: Aurora A/Flt3的选择性抑制剂
      ≥18.75 mg/mL
      insoluble in H2O
  10. Disulfiram
    A4015 Disulfiram
    中文名: 双硫仑
    Target: Aldehyde Dehydrogenases
    Summary: 多巴胺β-羟化酶抑制剂
      ≥12 mg/mL
      insoluble in H2O

10 件产品

每页